Literature DB >> 16157915

Ischemic stroke in young HIV-positive patients in Kwazulu-Natal, South Africa.

V B Patel1, Z Sacoor, P Francis, P L A Bill, A I Bhigjee, C Connolly.   

Abstract

Cerebrovascular disease occurs in HIV-positive individuals, but no relationship between the two has been established. The authors reviewed a cohort of patients aged 15 to 44 years to evaluate stroke in HIV-positive and negative subjects. Patients who were HIV-positive with no other identifiable etiology were compared to age- and race-matched HIV-negative patients. HIV-positive and HIV-negative groups did not differ in angiographic, cardiac, or serologic tests. A positive HIV test does not provide causal information or diagnosis.

Entities:  

Mesh:

Year:  2005        PMID: 16157915     DOI: 10.1212/01.wnl.0000174434.00402.b5

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  14 in total

1.  Greater Risk of Stroke of Undetermined Etiology in a Contemporary HIV-Infected Cohort Compared with Uninfected Individuals.

Authors:  Felicia C Chow; Richard W Price; Priscilla Y Hsue; Anthony S Kim
Journal:  J Stroke Cerebrovasc Dis       Date:  2017-03-02       Impact factor: 2.136

Review 2.  HIV and noncommunicable cardiovascular and pulmonary diseases in low- and middle-income countries in the ART era: what we know and best directions for future research.

Authors:  Gerald S Bloomfield; Prateeti Khazanie; Alison Morris; Cristina Rabadán-Diehl; Laura A Benjamin; David Murdoch; Virginia S Radcliff; Eric J Velazquez; Charles Hicks
Journal:  J Acquir Immune Defic Syndr       Date:  2014-09-01       Impact factor: 3.731

Review 3.  Cerebrovascular disease in HIV-infected individuals in the era of highly active antiretroviral therapy.

Authors:  Belinda Cruse; Lucette A Cysique; Romesh Markus; Bruce J Brew
Journal:  J Neurovirol       Date:  2012-04-14       Impact factor: 2.643

4.  Prevalence and Characteristics of HIV-Associated Stroke in a Tertiary Hospital Setting in South Africa.

Authors:  Craig Corbett; Naeem Brey; Richard D Pitcher; Suzanne O'Hagan; Tonya M Esterhuizen; Felicia C Chow; Eric H Decloedt
Journal:  Neurology       Date:  2022-06-03       Impact factor: 11.800

5.  Long-term predictive value of the Framingham Risk Score for Stroke in HIV-positive vs HIV-negative men.

Authors:  Farrah J Mateen; Wendy S Post; Ned Sacktor; Alison G Abraham; James T Becker; Bryan R Smith; Roger Detels; Eileen Martin; John P Phair; Russell T Shinohara
Journal:  Neurology       Date:  2013-11-08       Impact factor: 9.910

6.  Stroke in patients with human immunodeficiency virus infection.

Authors:  Brent Tipping; Linda de Villiers; Helen Wainwright; Sally Candy; Alan Bryer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04-30       Impact factor: 10.154

7.  Mitochondrial DNA impairment in nucleoside reverse transcriptase inhibitor-associated cardiomyopathy.

Authors:  James J Kohler; Seyed H Hosseini; William Lewis
Journal:  Chem Res Toxicol       Date:  2008-04-05       Impact factor: 3.739

8.  Stroke outcomes in Malawi, a country with high prevalence of HIV: a prospective follow-up study.

Authors:  Terttu Heikinheimo; Daniel Chimbayo; Johnstone J Kumwenda; Sam Kampondeni; Theresa J Allain
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

Review 9.  Stroke in Human Immunodeficiency Virus-infected Individuals in Sub-Saharan Africa (SSA): A Systematic Review.

Authors:  Amir Abdallah; Jonathan L Chang; Cumara B O'Carroll; Abdu Musubire; Felicia C Chow; Anthony L Wilson; Mark J Siedner
Journal:  J Stroke Cerebrovasc Dis       Date:  2018-04-05       Impact factor: 2.677

Review 10.  HIV infection and stroke: current perspectives and future directions.

Authors:  Laura A Benjamin; Alan Bryer; Hedley C A Emsley; Saye Khoo; Tom Solomon; Myles D Connor
Journal:  Lancet Neurol       Date:  2012-10       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.